Cystic Fibrosis in Children—Monitoring, Complications and New Therapies
A special issue of Children (ISSN 2227-9067). This special issue belongs to the section "Pediatric Pulmonary and Sleep Medicine".
Deadline for manuscript submissions: 15 June 2024 | Viewed by 1874
Special Issue Editors
Interests: cystic fibrosis; CF lung disease; exacerbations therapy; CF-associated liver disease; CF diabetes; CF modulators; CF therapy; CF elastography
Special Issue Information
Dear Colleagues,
Cystic fibrosis remains a challenging disease, whether in terms of diagnosis and treatment points of view, or regarding its multifaceted complications. Besides lung disease, the condition that dictates the disease outcome, more other comorbidities like liver disease and diabetes arise, complicating disease management, especially in children.
With the new use of modulators, the life expectancy is likely to upsurge. However, but further studies would be necessary in order to provide the best care for CF children. With increased life expectancy, more complications occur and several decisions must be taken in clinical practice.
As monitoring the disease is key to obtaining satisfactory outcome, new approaches like lung ultrasound, liver elastography or continuous glycemia monitoring requires appropriate evaluation and management. Deliver individual care to CF children is achievable and possible with the adaptation of new techniques and treatments to every patient.
This Issue addresses the cystic fibrosis diagnosis, monitoring and management of disease’s complications like lung disease exacerbations, and their relation to other non-respiratory complications like liver disease, diabetes, bone disease, endocrine dysfunctions and new treatments.
Prof. Dr. Ioana-Mihaiela Ciuca
Prof. Dr. Elpis Hatziagorou
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Children is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cystic fibrosis
- CF lung disease
- children
- CF modulators
- CF complication
- CF diabetes
- CF liver disease
- CF bone disease
- CF respiratory exacerbations
